We're all set for a new experience. To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open597
High657
Low597
Prev. Close645.5
Avg. Traded Price641.7
Volume3,61,817

MARKET DEPTH

info2
Total bid166.00
Total ask0.00
OrdersQtyBid
2166645.5
000
000
000
000
AskQtyOrders
000
000
000
000
000

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

597.0017 hours ago
657.0014 hours ago
arrow

LOWER/UPPER CIRCUITS

478.40
717.60
arrow
Unichem Laboratories Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 23.6%, in the last year to ₹2,146.29 Cr. Its sector's average revenue growth for the last fiscal year was 10.8%.
noteAnnual Net Profit,rose 295.13% in the last year to ₹137.52 Cr. Its sector's average net profit growth for the last fiscal year was 38.72%.
notePrice to Earning Ratio,is 27.96, lower than its sector PE ratio of 43.72.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 20.39%
Net profit growth 5Y CAGR : 0%
Unichem Laboratories Ltd Top mutual funds holding
arrow
Unichem Laboratories Limited, incorporated in 1962, is engaged in manufacturing formulations, pharmaceuticals and active pharmaceutical ingredients (APIs). The company has a strong footprint in the generic business for more than seven decades and has been at the forefront of supplying affordable medicines for patients and it offers a wide array of medicines in various therapeutic segments. The Company is exclusively in international business and the products manufactured are exported to many developed as well as developing countries.
personal

Grow your wealth with more research recommendations

+91